reported that combined treatment with ICD inducers and rock inhibitors enhanced the therapeutic effect of PD-1 blockers in mice with highly aggressive cold B16F10 tumors, targeting the primary tumor and inducing systemic antitumor immunity to inhibit metastasis (21). Here, PDCD1 is linked to neoplasm.